US FDA outlines manufacturing-focused stem cell research efforts – BioPharma-Reporter.com
BioPharma-Reporter.com |
US FDA outlines manufacturing-focused stem cell research efforts
BioPharma-Reporter.com In a blog post this week Food and Drug Administration (FDA) cellular and tissue therapy chief, Steve Bauer, outlined the potential of mesenchymal stem cell, the scientific hurdles the developers and regulators face and the agency's efforts to address them. |
